P01 SOW Attachment B Immunoassy Testing Reagents.docx

DOCX document 18 KB Posted

Attached to
6550--DIASORIN - 6 MONTH BRIDGE
Solicitation number
36C26226Q1269
Issued by

About this file

This is a Statement of Work (SOW) attachment specifying salient characteristics and other requirements for immunoassay testing reagents, supplies, and consumables to be provided to the Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 22 under solicitation 36C26226Q1269, a six-month bridge contract for DiaSorin immunoassay testing services.

The vendor must provide reagents, supplies, and consumables compatible with existing DiaSorin Liaison XL instruments utilizing Flash chemiluminescence technology with paramagnetic microparticle solid phase methodology. All products must be FDA-approved, with SARS-CoV-2 reagents meeting at minimum Emergency Use Authorization (EUA) standards. Reagents must employ internal master curves with two-part calibration systems and be ready-to-use with barcode identification for instrument compatibility. The vendor is responsible for servicing one DiaSorin Liaison XL instrument at the Long Beach location and ensuring products do not void existing instrument warranties. All shipping costs must be included in pricing on a FOB Destination basis, with orders requiring delivery within three business days of receipt. The requirement encompasses all reagents, supplies, and consumable parts necessary for analyzing and testing on all specified instruments.

View the file

Other files

File Type Posted
P02 Notice of Intent to Sole Source sources sought.docx DOCX document
Attachment A Reagents Bridge Contract.xlsx XLSX spreadsheet
36C26226Q1269.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Salient Characteristics Reagents, supplies and consumables must:

1. All reagents, supplies, and consumables must be compatible with existing DiaSorin Liaison XL instruments for immunoassay testing through “Flash” chemiluminescence technology (CLIA) with a paramagnetic microparticle solid phase (MP).

2. The use of the reagents, supplies, and consumables must not void the warranty on existing DiaSorin Liaison XL instruments.

3. The vendor shall provide the facilities with Food and Drug Administration (FDA) approved reagents and any consumable parts necessary for analyzing/testing on all instruments.

4. The vendor shall provide the facilities with at minimum Emergency Use Authorization (EUA) Food and Drug Administration (FDA) approved SARS-CoV-2 reagents and any consumable parts necessary for analyzing/testing on all instruments.

5. All assays must at minimum be based internal master curve with a two-part calibration.

6. All reagents and consumables shall be ready to use (i.e. no preparation by staff to prior to use).

7. All reagents and consumables shall have barcodes for instrument identification.

8. Service for one DiaSorin Liaison XL instruments at Long beach location.

Other Requirements

1. All shipping shall be inclusive of prices within the schedule and FOB Destination.

2. Orders must be delivered within three business days After Receipt of Order.

File details come from the government source that posted it. Updated .